Ubs Oconnor LLC Connect Biopharma Holdings LTD Transaction History
Ubs Oconnor LLC
- $1.72 Billion
- Q2 2024
A detailed history of Ubs Oconnor LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Ubs Oconnor LLC holds 510,701 shares of CNTB stock, worth $658,804. This represents 0.04% of its overall portfolio holdings.
Number of Shares
510,701Holding current value
$658,804% of portfolio
0.04%Shares
7 transactions
Others Institutions Holding CNTB
# of Institutions
13Shares Held
2.98MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.04MShares$2.64 Million2.22% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny212KShares$273,8670.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$134,0190.0% of portfolio
-
Keudell32.2KShares$41,5380.01% of portfolio
-
Geode Capital Management, LLC Boston, MA28KShares$36,0690.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $71M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...